Application of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria at a tertiary referral hospital.

BACKGROUND Application of current retinopathy of prematurity (ROP) screening criteria results in many unnecessary examinations, because only 5%-10% of infants screened require treatment. Application of screening criteria established by the Postnatal Growth and Retinopathy of Prematurity Study could significantly reduce unnecessary examinations without sacrificing sensitivity to detect treatment requiring ROP. We evaluated the performance of the G-ROP criteria in a population of high-risk, outborn infants. METHODS The medical records of consecutive infants screened and/or treated for ROP at Children's Health Care of Atlanta Hospitals from May 1, 2013, to September 6, 2019, were reviewed retrospectively. The sensitivity of the G-ROP birthweight and gestational age screening criteria to detect treatment-requiring ROP was calculated. RESULTS During the study period, 901 children underwent examinations for ROP; of these, 5 were excluded from the analysis because birth weight (BW) data was lacking. Of the 896 remaining patients, 120 patients were treated for ROP. Application of G-ROP birth weight and gestational age (GA) criteria alone resulted in a sensitivity of 99.2% to detect infants requiring treatment. Application of weight gain criteria was problematic, because many patients were transferred into our institutions after the specified intervals of 10-19, 20-29, and 30-39 days. CONCLUSIONS G-ROP BW and GA screening criteria were highly sensitive in detecting treatment-requiring ROP. Applying weight gain criteria in referral centers can be problematic. Intake procedures at referral centers should include documentation of weight gain during 10-19, 20-29, and 30-39 days of life.

• Publication year

  2022

• Venue

  Journal of AAPOS

• Publication date

  2022-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaapos.2021.08.309PMID 35158048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Japanese Cohort.

  2019cited by this paper
• Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria.

  2019cited by this paper
• Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study

  2018cited by this paper
• Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity

  2013cited by this paper
• Severe retinopathy of prematurity associated with FZD4 mutations

  2010cited by this paper
• Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

  2004cited by this paper
• Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.

  2003cited by this paper
• Screening Examination of Premature Infants for Retinopathy of Prematurity

  1997cited by this paper

• Global Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Model: A Systematic Review and Meta-analysis.

  2026cites this paper
• Modifiable Risk Factors and Preventative Strategies for Severe Retinopathy of Prematurity

  2023cites this paper
• Retrospective cohort evaluation of postnatal growth and retinopathy of prematurity (G‐ROP) criteria in a tertiary centre in Turkey

  2023cites this paper
• Validation of the Postnatal Growth and Retinopathy of Prematurity (GROP) screening criteria

  2022cites this paper